RecruitingNot ApplicableNCT06019910

Snus and Home Blood Pressure

The Effects of Snus on Home Blood Pressure and Metabolism

Sponsor

University Hospital, Linkoeping

Enrollment

28 participants

Start Date

Oct 9, 2023

Study Type

INTERVENTIONAL

Conditions

Obesity Blood Pressure Dyslipidemias Dysglycemia

Summary

Snus is a type of snuff that is administered sublabially, that has not been studied regarding the effects on home blood pressure and metabolism on a longer time frame. The primary aim of this study is to evaluate the effect of snus on home BP within weeks to months in former snus users who continue to not use snus or relapse in daily snus use, respectively. The secondary aim is to evaluate the effects on metabolic measurements. The hypothesis is that BP will increase amongst the participants that resume snus intake. 28 healthy volunteers with a pre-existing daily use of snus will be recruited and followed during snus cessation. Home blood pressure, lipid and metabolic markers will be measured before and after snus cessation, as well as after snus relapse if such a relapse occurs.

Eligibility

Min Age: 18 YearsMax Age: 50 Years

Inclusion Criteria2

daily use (defined as at least once daily for at least 1 month) o snus
the ability to use online questionnaires written and answered in Swedish

Exclusion Criteria5

simultaneous use of any other nicotine or tobacco product (including cigarette smoking, e-cigarettes, and nicotine replacement therapy)
drug use (including cannabis)
alcohol dependence
known cardiovascular disease (including hypertension, previous myocardial infarction, stroke, peripheral arterial disease, or angina pectoris), kidney disease, hormonal disease (including diabetes mellitus) or eating disorder
current or planned pregnancy.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSnus with or without tobacco

At baseline, participants have used the intervention daily for at least 30 days. They will then cease usage of the intervention abruptly. After 3 weeks, they may continue to abstain from the intervention or relapse at their own discretion.